EVAX
Price
$3.15
Change
-$0.04 (-1.25%)
Updated
Feb 4, 04:42 PM (EDT)
Capitalization
26.61M
Intraday BUY SELL Signals
KURA
Price
$8.06
Change
-$0.17 (-2.07%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
702.23M
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EVAX vs KURA

Header iconEVAX vs KURA Comparison
Open Charts EVAX vs KURABanner chart's image
Evaxion A/S
Price$3.15
Change-$0.04 (-1.25%)
Volume$100
Capitalization26.61M
Kura Oncology
Price$8.06
Change-$0.17 (-2.07%)
Volume$23.58K
Capitalization702.23M
EVAX vs KURA Comparison Chart in %
EVAX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EVAX vs. KURA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (EVAX: $3.19 vs. KURA: $8.23)
Brand notoriety: EVAX and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 92% vs. KURA: 78%
Market capitalization -- EVAX: $26.1M vs. KURA: $702.23M
EVAX [@Biotechnology] is valued at $26.1M. KURA’s [@Biotechnology] market capitalization is $702.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both EVAX and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • EVAX’s TA Score: 4 bullish, 4 bearish.
  • KURA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EVAX is a better buy in the short-term than KURA.

Price Growth

EVAX (@Biotechnology) experienced а -20.45% price change this week, while KURA (@Biotechnology) price change was -2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($702M) has a higher market cap than EVAX($26.6M). KURA YTD gains are higher at: -20.789 vs. EVAX (-33.124). EVAX has higher annual earnings (EBITDA): -5.06M vs. KURA (-212.24M). KURA has more cash in the bank: 550M vs. EVAX (10.6M). EVAX has less debt than KURA: EVAX (11.3M) vs KURA (19.5M). KURA has higher revenues than EVAX: KURA (104M) vs EVAX (7.65M).
EVAXKURAEVAX / KURA
Capitalization26.6M702M4%
EBITDA-5.06M-212.24M2%
Gain YTD-33.124-20.789159%
P/E RatioN/AN/A-
Revenue7.65M104M7%
Total Cash10.6M550M2%
Total Debt11.3M19.5M58%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAXKURA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 29 days ago
84%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NNNN27.222.56
+10.38%
Anbio Biotechnology
HWBK35.680.77
+2.21%
Hawthorn Bancshares
RDNT70.11-0.76
-1.07%
RadNet
JOB0.23N/A
-1.33%
GEE Group
BK119.32-2.29
-1.88%
Bank of New York Mellon Corp

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with ABSI. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+2.90%
ABSI - EVAX
33%
Loosely correlated
+2.32%
OMER - EVAX
33%
Poorly correlated
+0.85%
KURA - EVAX
31%
Poorly correlated
-0.48%
GNPX - EVAX
31%
Poorly correlated
-3.61%
RXRX - EVAX
31%
Poorly correlated
-1.91%
More